News & Events

WATCH: Advanced Therapeutics Webinar Series 9: The growing demand for viral vectors as a cutting-edge health treatment

16 March 2023
Advanced Therapeutics

Webinar series

Advanced Therapeutics: The growing demand for viral vectors as a cutting-edge health treatment In our next webinar we will be taking a deeper look at viral vectors and the subsequent explosion of therapeutic possibilities. These key components of gene therapies for rare genetic diseases and cell therapies for cancer are now in growing demand for use in both research and clinical trials, in Aus...

NSW Caretaker Period has commenced

02 March 2023
Announcement

Public health information will continue to be updated on this site. However, no ministerial press releases or related information issued by the Government from this date will be available on this website. For copies of recently issued ministerial press releases or information on the election policies of any political party as they relate to this department/agency or its portfolio area, plea...

WATCH: Advanced Therapeutics Webinar Series 10: a look at how gene therapy is changing the game for children with SMA

11 November 2022
Advanced Therapeutics

Photo of a sleeping baby in relation to Kids Research Spinal Muscular Atrophy trials and success

Webinar series

Advanced Therapeutics: No longer science fiction – a look at how gene therapy is changing the game for children with SMA In our upcoming webinar, we will be visiting the topics of newborn bloodspot screen and genetic therapies in the context of treating Spinal Muscular Atrophy (SMA). We will hear from a panel of speakers who will discuss our centres success in establishing a multidisciplinary...

Cancer research enters 'The Matrix'

29 August 2022
Cancer research

Cancer research

A researcher’s vision to analyse genes of young cancer patients to personalise their treatment has now become a virtual reality. Twenty years ago, Associate Professor Daniel Catchpoole developed an idea to examine complex data and deliver precision medicine through an immersive experience. Now, a prototype for ‘Virtual Reality for the Observation of Oncology Models’, VROOM for short, has be...

Lockdowns decrease paediatric asthma presentations

03 August 2022
Research

Respiratory research

Lockdowns led to a dramatic decrease in the number of young people taken to Sydney hospitals for their asthma during the pandemic. These are the findings from a new study, published in Springer Nature, investigating the impact of the three COVID-19 waves in NSW on paediatric asthma-related hospital presentations. The research found a significant decline in presentations while stay-at-home rest...

WATCH: Advanced Therapeutics Webinar 8: A health system team approach to ocular gene therapy and vision rescue

02 August 2022
Gene therapy

Webinar series

In the 8th episode of our Advanced Therapeutics Webinar series we revisited the topic of ocular gene therapy with our biggest panel of speakers this year. Since LUXTURNA’s success as a world-first gene replacement therapy for an RPE65-related retinal vision loss early last year, our researchers have made great strides in paving the way for the treatment of patients with all kinds of...

Funding boost for cutting-edge health treatments

24 June 2022
Gene therapy

Viral Vector Facility

Kids Research welcomes the NSW government’s funding boost for biomedical research, putting the state at the forefront of cutting-edge health treatments. The Perrottet government has secured $270 million, announced in the state budget, to go towards two new facilities; the Viral Vector manufacturing facility at Westmead and the Sydney Biomedical Accelerator Complex in Camperdown. Premier Domini...

SCHN gene therapy experts speak at global events

21 June 2022
Gene therapy

Gene therapy

World-leading gene therapy experts at Sydney Children’s Hospitals Network (SCHN) have shared their knowledge and experience on a global stage. Researchers, Professor Ian Alexander and Associate Professor Michelle Farrar have spoken at separate conventions in California, after being honoured with an invitation to the events. The pair led the only Australian clinical trial of gene th...

Study confirms COVID-19 cases higher than reported

20 June 2022
COVID-19

COVID-19 study

A new study has found the number of Australian adults infected with COVID-19 at the end of February, was at least twice as high as cases reported to authorities. At least 17 per cent of adults are estimated to have recently been infected with SARS-CoV-2, the virus that causes COVID-19, with the majority of these infections believed to have occurred during the Omicron wave. This result, rele...

World-first treatment changes outlook for SMA babies

18 June 2022
Gene therapy

World-first SMA treatment

Babies diagnosed with Spinal Muscular Atrophy (SMA) at birth who received life-changing gene therapy are now celebrating their first birthday symptom-free or with minimal symptoms thanks to Sydney Children’s Hospitals Network’s (SCHN) world-first clinical trial. The SPR1NT trial, published in the prestigious journal Nature Medicine (two copies of SMN2 and three copies of SMN2), successfull...

1
2
3
4
5
6
7
…
next-page

News & Events

Addresses

General Enquires

Links

Partners

Address

General Enquires

Links

Partners